Loading…
CIK 0001844645 • 6 13F filings • May 14, 2025 – Aug 13, 2026
Import this data to Google Sheets with:
=jivedata("pivotal-bioventure-partners-investment-advisor-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ARCUTIS BIOTHERAPEUTICS INC | COM | $33.2M | 26.8% | 2,120,508 SH | |
| BIOAGE LABS INC | COM | $2.5M | 2.0% | 653,374 SH | |
| BOLT BIOTHERAPEUTICS INC | COM | $757K | 0.6% | 1,891,467 SH | |
| INOZYME PHARMA INC | COM | $4.1M | 3.3% | 4,494,851 SH | |
| IO BIOTECH INC | COM | $942K | 0.8% | 864,197 SH | |
| OCULIS HOLDING AG | ORDINARY SHARES | $43.8M | 35.4% | 2,300,774 SH | |
| RALLYBIO CORP | COM | $1.6M | 1.3% | 2,404,644 SH | |
| RECURSION PHARMACEUTICALS IN | CL A | $3.2M | 2.5% | 595,518 SH | |
| VAXCYTE INC | COM | $26.8M | 21.7% | 710,734 SH | |
| VIGIL NEUROSCIENCE INC | COM | $998K | 0.8% | 560,595 SH | |
| ZENAS BIOPHARMA INC | COM | $5.8M | 4.7% | 736,645 SH |
| Q2 2026 |
| 13F-HR |
| 0001012975-26-000759 |
| $307.8M |
| View |
| Aug 13, 2025 | Q2 2025 | 13F-HR | 0001012975-25-000438 | $161.3M | View |
| May 14, 2026 | Q1 2026 | 13F-HR | 0001012975-26-000421 | $279.8M | View |
| May 14, 2025 | Q1 2025 | 13F-HR | 0001012975-25-000233 | $123.6M | View |